FEDERAL · 21 U.S.C. · Chapter SUBCHAPTER V—DRUGS AND DEVICES

Clinical trial guidance for antibiotic drugs

21 U.S.C. § 360a
Title21Food and Drugs
ChapterSUBCHAPTER V—DRUGS AND DEVICES
PartA

This text of 21 U.S.C. § 360a (Clinical trial guidance for antibiotic drugs) is published on Counsel Stack Legal Research, covering United States primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
21 U.S.C. § 360a.

Text

(a)In general Not later than 1 year after September 27, 2007, the Secretary shall issue guidance for the conduct of clinical trials with respect to antibiotic drugs, including antimicrobials to treat acute bacterial sinusitis, acute bacterial otitis media, and acute bacterial exacerbation of chronic bronchitis. Such guidance shall indicate the appropriate models and valid surrogate markers.
(b)Review Not later than 5 years after September 27, 2007, the Secretary shall review and update the guidance described under subsection (a) to reflect developments in scientific and medical information and technology.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Kuch
288 F. Supp. 439 (District of Columbia, 1968)
73 case citations
Russell W. White v. United States
399 F.2d 813 (Eighth Circuit, 1968)
64 case citations
United States v. Alois Peter Warren
453 F.2d 738 (Second Circuit, 1972)
60 case citations
Woods & Rohde, Inc. v. State, Department of Labor
565 P.2d 138 (Alaska Supreme Court, 1977)
56 case citations
United States v. Clarence Arnold
425 F.2d 204 (Tenth Circuit, 1970)
53 case citations
United States v. Terry Lee Schafer
461 F.2d 856 (Ninth Circuit, 1972)
46 case citations
United States v. Clarke Raymond Moore and John Bernard Spelz
452 F.2d 569 (Sixth Circuit, 1971)
38 case citations
United States v. Bill Lee Cummings, Etc.
468 F.2d 274 (Ninth Circuit, 1972)
38 case citations
United States v. Robert Cerrito
413 F.2d 1270 (Seventh Circuit, 1969)
34 case citations
In re Neurontin Marketing & Sale Practices Litigation
244 F.R.D. 89 (D. Massachusetts, 2007)
20 case citations
United States v. Angelo v. Graci
504 F.2d 411 (Third Circuit, 1974)
19 case citations
Dennis C. Deyo v. United States
396 F.2d 595 (Ninth Circuit, 1968)
17 case citations
Andresen v. BAR ASS'N OF MONT. CTY.
305 A.2d 845 (Court of Appeals of Maryland, 1973)
15 case citations
United States v. Anile
352 F. Supp. 14 (N.D. West Virginia, 1973)
15 case citations
Owsley Stanley v. United States
400 U.S. 936 (Supreme Court, 1970)
14 case citations
United States v. Stephen L. Soltow
444 F.2d 59 (Tenth Circuit, 1971)
12 case citations
United States v. Willie Alro Kelly
500 F.2d 72 (Seventh Circuit, 1974)
12 case citations

Source Credit

History

(June 25, 1938, ch. 675, §511, as added Pub. L. 110–85, title IX, §911, Sept. 27, 2007, 121 Stat. 951.)

Editorial Notes

Editorial Notes

Prior Provisions
A prior section 360a, act June 25, 1938, ch. 675, §511, as added July 15, 1965, Pub. L. 89–74, §3(b), 79 Stat. 227; amended Oct. 24, 1968, Pub. L. 90–639, §2(a), 82 Stat. 1361, regulated the manufacture, compounding, and processing of depressant and stimulant drugs and their sale, delivery, disposal, possession, and recordkeeping activities connected therewith, prior to repeal by Pub. L. 91–513, title II, §§701(a), 704, Oct. 27, 1970, 84 Stat. 1281, 1284, effective on the first day of the seventh calendar month that began after Oct. 26, 1970.

Cite This Page — Counsel Stack

Bluebook (online)
21 U.S.C. § 360a, Counsel Stack Legal Research, https://law.counselstack.com/usc/21/360a.